The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
As I thought, no sparkles on the day of the results. One thing I've picked up with this, if the SP jumps on the news of robust results, as was the case with this stock, expect 'buy the news, sell the facts' scenario to play out. As for the great fall in SP, it's a penny stock. We are all in it for an instant gratification. With all what the board has said, expecting this to fall at least up to 3.5p before any upward move.
They are virtually at end of H1-2022 (5 weeks to go), so sales stabilising now will be too late for H1-2022 and the 'hope' is things will improve for H2-2022.
With increasing number of people being vaccinated and covid restrictions removed, I think the demand for sanitiser etc will reduce further.
"But revenue from product sales is expected to fall by 10% to 20% in financial 2022. Sales since March 31 have been hindered by venues being shut in lockdown, new competition and an excess of inventory, although the market is now stabilising."
I see a number of big buy trades have gone through this afternoon. Just hope the directors get involved too
Ditto. Clearly it's an awful day for the market. If people are scared it's the start of a crash and they see this start to fall they'll sell anyway. "There must be a reason...."
But I wonder if it is the outlook as well: they had a huge Covid boost and hit such a high a year ago, but like VLG are being hit by overstocking (and new competitors) which has to be worked through. BUT.... they say it is stabilising now, and medium to long term is great. Especially like the licence income.
"Outlook and current trading
The sanitiser market has experienced a period of unprecedented activity as a result of COVID-19, resulting in record financial performance for Byotrol. We believe the increase in anti-microbial awareness and mass-uptake of related products will continue long into the future.
Management remains extremely positive on the medium to long-term outlook where the market is forecast to grow globally at 8 to 10% per year from pre-COVID levels and industry earnings growth is likely to exceed this as weaker competitors with inferior chemistries, and those that lack regulatory approval, fall away.
In the short-term, revenue from product sales in the new financial year to date has been hindered by closed venues from extended lockdowns, new competition, and an excess of inventory. However, the market does now appear to be stabilising and management now expect product sales for FY22 at a level some 10 to 20% below those for FY21: an exceptional year which was itself over 90% ahead of FY20."
And they are in profit, no debt, and you can hardly say this whopping result was priced in. May top up, when it looks like it's stabilised. You could hardly this coming year to have sales like the last: 10-20% below seems pretty good to me, seeing it's so much up on the year before. Seems likely to me that many buyers have discovered their virtues and they expect will stay with them.
I really thought these were great financials and was expecting a nice rise today, WTF, I dont understand it. Clearly the market was expecting much more. Hopefully they will creep upwards soon
I can’t understand what is happening here. Seemingly good news and everyone is dumping the stock. We must all be hoping for some positive comment in the MoS this week.
All we can do is sit tight and just hope it c9mes back
Not a peep from anyone. Volume's in excess of 3 million now, so I guess you all have sold yours and busy digesting those multi-digit losses. Come next week, I might need to congratulate you all for that 50%+ loss trade as we're heading to zero clearly. I do hope the tide turns around though. The 4.5p bid must hold.
So if the results are all that rosy, why are these retail holders dumping 200k shares every minute? Volume's 2m+ on the day so far, and this indiscriminate selling's just keeps gathering pace. Why's everyone so desperate to take huge losses in a company with such optimistic prospects? Are they being irrational? All I see is a sea of red as if Byotrol said they were going under.
Sounds good to me. Also IP licensing seeing "the start of an extremely high-margin and high-profile revenue stream".
https://www.londonstockexchange.com/news-article/BYOT/final-results/15104000
Commenting on the results, John Langlands, Chairman of Byotrol plc, said:
"This past year was an extraordinary one by any standards, in our industry and in society in general. Byotrol's financial results to March 2021 were our best ever, boosted by demand for our products due to COVID-19, but we believe will continue to benefit from new post-pandemic approaches to infection prevention in institutional, business and consumer environments.
We continue to see many opportunities on our markets and continually review how best to maximise returns from them. Your Board remains optimistic for Byotrol's prospects."
Venture Life interim revenues slip as hand sanitiser sales fall
https://www.sharecast.com/news/aim-bulletin/venture-life-interim-revenues-slip-as-hand-sanitiser-sales-fall--8063393.html
19 August 2021. You should checkout their stats!!
Cor blimey, what happened today, does anyone know? No news whatsoever and obscene amounts of selling making me feel like the last of the Mohicans!
Everything you need to know about this stock happened in 2006. A brilliant idea, patent & launch. All key markets, customer and sectors engaged, the pinnacle being healthcare: a partner and access to the NHS. Then the slip-ups, starting with a tall tale shooting the SP to 74p with enough unease to grease the slope downwards ever since. Miss-managed with some style.
Results were expected in July, so they missed their own stated date.
It doesn't do reputation much good when a company repeatedly misses the results announcement date.
It would have been better not to state the results date in their Apr TU. Investors would have expected them in Sept and results in Aug would have been seen as a positive.
"We expect to announce our final results in July."
https://byotrolplc.com/wp-content/uploads/2021/04/2021-04-21-TU-approved-pdf.pdf
I'm sitting on fence with this one. Not expecting it to jump when the results are out. SP was up 7.2 in April when they forecasted a robust FY performance so expecting no sparks on the day. Fundamentals look good but no broker coverage since 2016 leaves it with no guidance and makes it look like a forgotten stock. TIGGR report gives hope and makes it a buy but that's putting too much hope in one basket. This stock just needs a scandalous report against alcohol based products for it to shine.
Wishful thinking looks like I’ve read an old report
They’re due on 19 August.
Hopefully some positive coverage in MoS will drive price higher
Ticking up nicely towards the results:))
Results due soon and should be excellent imo :))
Read the article, they mention Boots, as they have done in previous articles.
Look at the online sales of the Boots product.
50ml bottle:
It currently shows < 10 sold in last 24 hrs.
https://www.boots.com/boots-anti-viral-hand-foam-50ml-10278907
Same with the 200ml bottle.
11 sold in last 24 hrs.
https://www.boots.com/boots-anti-viral-hand-foam-200ml-10278908
These were around 100 bottles over 24 hrs in the early days of the Pandemic.
17th Aug 2020:
Midas recommended Byotrol, referencing Boots brand as one of the reasons to buy:
https://www.thisismoney.co.uk/money/investing/article-8630601/MIDAS-SHARE-TIPS-clean-Byotrol.html?mrn_rm=rta
17th Aug to 24th Aug:
within days, the sp shot up from 6.3p to around 10p.
https://uk.finance.yahoo.com/quote/BYOT.L/history?p=BYOT.L
However, the following week, the sp started falling back again.
23rd Sept - fy2020
https://byotrolplc.com/wp-content/uploads/2020/09/2020-09-23-Prelims-RNS-FINAL-pdf.pdf
the sp was drifting back down towards 6p.
7th Dec - just 2.5 months after fy results, they published the interims, H1 2021.
https://byotrolplc.com/wp-content/uploads/2020/12/H1-2021-1.7.pdf
The sp on 7th Dec was around 6.5p-7p and drifted lower.
Given the sp is back to where it was pre-the Aug Midas recommendation based on events and so made no difference last time, why should it make difference this time?
Check the interims and sp history yourselves.
Read through the previous posts on here and it's clear some PIs weren't happy with the performance, having bought in on the Midas tip.
If you insist on repeating your previous biased post then I must repeat my reply
stt selective parts from the interims that actually read
Significant improvement in financial performance:
-- Sales trebled to GBP6.7m compared to GBP2.2m in H1 2020 (and GBP6.1m for the full year to 31 March 2020)
-- Gross profit on product sales increased to GBP2.3m from GBP0.9m
-- Adjusted EBITDA * increased to GBP1.2m compared to a loss of GBP0.4m in H1 2020
-- Net cash and cash equivalents of GBP1.7m at period end after substantial investment in stock
Here's the same poster on the other site with his other shorting friend back in Feb last year
ikhthetech 20 Feb '20 - 10:47 - 4540 of 7660 0 0 4
Brownson
"I fear byotrol has missed the boat. "
"The public (and commercial customers) will have forgotten all about this in another couple of weeks."
Exactly. Covid-19 isn't even front page news anymore.
Not to be trusted at all and as you can see not exactly right
According to this SKY article, UK dropped WHO guidance before the 1st lockdown.
Coronavirus: UK dropped WHO guidance on alcohol-based hand sanitisers before lockdown
https://news.sky.com/story/coronavirus-uk-dropped-who-guidance-on-alcohol-based-hand-sanitisers-before-lockdown-12056746
Yet, H1 global consumer sales increased Consumer sales by only £590k to around £1m, during the busy pandemic period, H1 Apr-Sept, so any lower would be shocking!.
That includes Boots, Homeandcleaning, direct website sales etc etc...Global consumer sales.
Consumer:
"H1 revenues more than doubled to £1.01m from £0.41m, including a small amount of IP-based income, versus nil IP income in the comparable period. Gross profit (on products) increased to £0.43m from £0.17m. "
"Elsewhere, sales across existing customers all increased in this segment, especially into Japan via our longstanding agents in pet and healthcare."
https://byotrolplc.com/wp-content/uploads/2020/10/FY-2020-web.pdf
Apart from that alcohol free sanitiser is widely available.
As with demand for any product, other companies adapt and enter the market.
Results due next month, so not long now.
Best wait to see what they have to say.
This view from the stt1 who has consistently knocked this stock since it was less than 1.5p.
So, from a tiny demand for non-alcohol sanitiser (due to WHO giving incorrect/wrong advice), the demand will rise ... most likely a lot because it is so much nicer to use than alcohol based sanitisers. Quite possibly demand will be more than 25%. Byotrol have 92% of the NHS covered, so as usage increases this can only be good for Byotrol. A lot to like here for investors.